A positive correlation between the PDL1 levels on tumor cells, IL-12 production by engineered NK cells, and increased IFNγ secretion highlighted the immunostimulatory potential of this construct against the PDL1-expressing tumor cells (Figure 5). This evidence concerns the gene CD274 and neoplasm.